Your browser doesn't support javascript.
loading
The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study.
Van't Hoog, A H; Bergval, I; Tukvadze, N; Sengstake, S; Aspindzelashvili, R; Anthony, R M; Cobelens, F.
Afiliação
  • Van't Hoog AH; Department of Global Health, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. a.h.vanthoog@aighd.org.
  • Bergval I; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. a.h.vanthoog@aighd.org.
  • Tukvadze N; KIT Biomedical Research, Royal Tropical Institute, Amsterdam, The Netherlands. i.bergval@kit.nl.
  • Sengstake S; National Tuberculosis Reference Laboratory, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia. marikushane@yahoo.com.
  • Aspindzelashvili R; KIT Biomedical Research, Royal Tropical Institute, Amsterdam, The Netherlands. s.sengstake@kit.nl.
  • Anthony RM; National Tuberculosis Reference Laboratory, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia. asporusiko@yahoo.com.
  • Cobelens F; KIT Biomedical Research, Royal Tropical Institute, Amsterdam, The Netherlands. r.anthony@kit.nl.
BMC Infect Dis ; 15: 473, 2015 Oct 26.
Article em En | MEDLINE | ID: mdl-26503434

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla / Ensaios de Triagem em Larga Escala / Mutação Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla / Ensaios de Triagem em Larga Escala / Mutação Idioma: En Ano de publicação: 2015 Tipo de documento: Article